Summary of earning per share basic and diluted reconciliation |
The following table reflects the calculatio n of basic and diluted net income (loss) per share (in dollars, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2021 |
|
|
2020 |
|
Class A Common stock subject to possible redemption |
|
|
|
|
|
|
|
|
Numerator: Earnings allocable to Class A common stock subject to possible redemption |
|
|
|
|
|
|
|
|
Interest earned on marketable securities held in Trust Account |
|
$ |
37,333 |
|
|
$ |
1,088,046 |
|
Unrealized gain on marketable securities held in Trust Account |
|
|
3,948 |
|
|
|
340,728 |
|
Less: interest available to be withdrawn for payment of taxes |
|
|
(39,585 |
) |
|
|
(296,216 |
) |
|
|
|
|
|
|
|
|
|
Net income attributable to Class A common stock subject to possible redemption |
|
$ |
1,696 |
|
|
$ |
1,132,558 |
|
|
|
|
|
|
|
|
|
|
Denominator: Weighted Average Class A Common stock subject to possible redemption |
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
|
|
28,793,444 |
|
|
|
28,488,312 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net income per share, Class A common stock subject to possible redemption |
|
$ |
0.00 |
|
|
$ |
0.04 |
|
|
|
|
|
|
|
|
|
|
Non-Redeemable Common Stock |
|
|
|
|
|
|
|
|
Numerator: Net Loss minus Net Earnings |
|
|
|
|
|
|
|
|
|
|
$ |
(12,870,990 |
) |
|
$ |
6,442,454 |
|
Less: Net income allocable to Class A Common stock subject to possible redemption |
|
|
(1,696 |
) |
|
|
(1,132,558 |
) |
|
|
|
|
|
|
|
|
|
Non-Redeemable Net (Loss) Income |
|
$ |
(12,872,686 |
) |
|
$ |
5,309,896 |
|
|
|
|
|
|
|
|
|
|
Denominator: Weighted Average Non-Redeemable Common Stock |
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock |
|
|
10,737,806 |
|
|
|
11,565,826 |
|
|
|
|
|
|
|
|
|
|
Basic and diluted net (loss) income per share, Non-redeemable common stock |
|
$ |
(1.20 |
) |
|
$ |
0.46 |
|
|
|
|
|
|
|
|
|
|
|
(1) |
The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 24,137,500 shares in the calculation of diluted income (loss) per share, since the inclusion of such warrants would be anti-dilutive. |
|